Naomi Robertson
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents 3
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 5
- Molecular Biology top 10%
- Chemical Synthesis and Analysis 7
- Epigenetics and DNA Methylation 4
- Cancer therapeutics and mechanisms 4
- Histone Deacetylase Inhibitors Research 4
- Organic Chemistry top 5%
- Click Chemistry and Applications 7
- Oncology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- Adrian L. HarrisChristian PotterIan J. StratfordChristine BlancherJohn W. MooreDavid R. SpringG.E. AdamsJohn W. R. Schwabe
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
Naomi Robertson
33 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 96
- Toxicology 150
- Cancer Research 378
- Molecular Biology 1.2k
- Organic Chemistry 392
- Oncology 252
Countries citing papers authored by Naomi Robertson
This map shows the geographic impact of Naomi Robertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Robertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Robertson more than expected).
Fields of papers citing papers by Naomi Robertson
This network shows the impact of papers produced by Naomi Robertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Robertson. The network helps show where Naomi Robertson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naomi Robertson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2020 | 88 | |
| 3 | 2019 | 20 | |
| 4 | 2019 | 3 | |
| 5 | 2018 | 40 | |
| 6 | 2018 | 108 | |
| 7 | 2016 | 184 | |
| 8 | 2015 | 17 | |
| 9 | 2008 | 38 | |
| 10 | 2008 | 6 | |
| 11 | 2006 | 2 | |
| 12 | 2006 | 4 | |
| 13 | 2006 | 1 | |
| 14 | Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. | 2001 | 226 |
| 15 | 5-Substituted analogues of 3-hydroxymethyl-5-aziridinyl-1-methyl-2-[1H-indole-4, 7-dione [prop-2-en-1-ol (EO9, NSC 282459) and their regioisomers as hypoxia-selective agents: structure-cytotoxicity in vitro | 1998 | 5 |
| 16 | 1995 | 11 | |
| 17 | 1994 | 71 | |
| 18 | 1994 | 48 | |
| 19 | 1994 | 23 | |
| 20 | 1992 | 72 |
About Naomi Robertson
Naomi Robertson is a scholar working on Toxicology, Organic Chemistry and Molecular Biology, having authored 33 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (7 papers), Click Chemistry and Applications (7 papers), Cancer, Hypoxia, and Metabolism (5 papers), Epigenetics and DNA Methylation (4 papers), Cancer therapeutics and mechanisms (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Toxicology (150 citations), Cancer Research (378 citations) and Molecular Biology (1.2k citations). Naomi Robertson has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Adrian L. Harris, Christian Potter, Ian J. Stratford, Christine Blancher, John W. Moore, David R. Spring, G.E. Adams, John W. R. Schwabe, Andrew G. Jamieson and Shaun M. Cowley. Their work appears in journals such as Nature Communications, Cancer Research and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.